Avicenna Hand develops AI-supported software for bionic hands that enhance dexterity and functionality for individuals with limb loss. The technology addresses the limitations of traditional prosthetics by providing users with intuitive control and improved adaptability to various tasks.
Funding
$12M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals with limb loss often face challenges with traditional prosthetic hands, which can lack the dexterity and intuitive control needed for performing a wide range of daily tasks. Current prosthetic solutions may not adequately adapt to the varying demands of different activities, limiting the user's functionality and independence.
Solution
Avicenna Hand develops AI-powered software designed to enhance the functionality and usability of bionic hands. Their technology aims to overcome the limitations of conventional prosthetics by providing users with more intuitive control and improved adaptability. The software utilizes artificial intelligence algorithms to learn and predict the user's intended movements, enabling more natural and fluid hand motions. By integrating AI, Avicenna Hand seeks to provide a prosthetic solution that closely mimics the dexterity and responsiveness of a natural hand, empowering users to perform a wider array of tasks with greater ease and confidence.
Target Audience
The primary target audience includes individuals with upper limb loss seeking advanced prosthetic solutions, as well as prosthetists and rehabilitation specialists looking to offer cutting-edge technology to their patients.
Features
- AI-driven motion prediction for intuitive prosthetic hand control
- Adaptive algorithms that learn and personalize to individual user patterns
- Enhanced dexterity for performing complex and fine motor tasks